Oncology Biopharma TESARO (TSRO) Files $86.25M IPO

TESARO, Inc. (Nasdaq: TSRO), filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $86.25 million. TESARO plans to list on the Nasdaq Global Market under the ticker "TSRO."

The offering is being made through Citigroup, Morgan Stanley, Leerink Swann, BMO Capital Markets, and Baird.

TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SpaceX Shares Indicated To Open At $155
• Laser Photonics regains NASDAQ compliance after filing quarterly report
• Momentus prices $25 million stock offering with institutional investors